Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Propylthiouracil-induced hypersensitivity vasculitis presenting as respiratory failure.

S J Stankus1, N T Johnson

  • 1Madigan Army Medical Center, Department of Family Practice, Fort Lewis, WA 98431-5000.

Chest
|November 1, 1992
PubMed
Summary

Propylthiouracil can cause hypersensitivity vasculitis, rarely presenting as lung problems. Prompt treatment with steroids and stopping the drug resolved severe respiratory issues and lung infiltrates.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Management of herpes zoster (shingles) and postherpetic neuralgia.

American family physician·2000
Same author

Uvulopalatopharyngoplasty and inferior sagittal mandibular osteotomy with genioglossus advancement for treatment of obstructive sleep apnea.

Chest·1994
Same author

Autoregulation of beat frequency in respiratory ciliated cells. Demonstration by viscous loading.

The American review of respiratory disease·1991
Same author

Acute acquired demyelinating polyneuropathy with respiratory failure following high-dose systemic cytosine arabinoside and marrow transplantation.

Bone marrow transplantation·1987
Same author

beta-Adrenergic stimulation of respiratory ciliary activity.

Journal of applied physiology: respiratory, environmental and exercise physiology·1980

Area of Science:

  • Internal Medicine
  • Pulmonology
  • Rheumatology

Background:

  • Propylthiouracil (PTU) is a common antithyroid medication used to treat hyperthyroidism.
  • Hypersensitivity vasculitis (HSV) is a known adverse reaction to PTU, typically affecting the skin.
  • Pulmonary involvement in PTU-induced HSV is rare, with few documented cases.

Observation:

  • A 72-year-old woman developed respiratory failure and hemoptysis after starting PTU for Graves' disease.
  • The patient exhibited skin lesions characteristic of HSV and widespread lung infiltrates.
  • These symptoms emerged shortly after initiating PTU therapy.

Findings:

  • The patient's clinical presentation included severe respiratory distress and coughing up blood.
  • Diagnostic workup revealed diffuse pulmonary infiltrates on imaging.

Related Experiment Videos

  • Skin biopsy confirmed vasculitis consistent with hypersensitivity.

    • Implications:

    • This case highlights the unusual presentation of PTU-induced HSV with primary pulmonary involvement.
    • Early recognition and withdrawal of PTU, along with corticosteroid treatment, are crucial for managing severe pulmonary manifestations.
    • Physicians should consider PTU-induced vasculitis in patients with unexplained respiratory symptoms and skin lesions, even if pulmonary involvement is atypical.